Medicine and Dentistry
Diabetes
100%
Maturity Onset Diabetes of the Young
39%
Cardiovascular Disease
24%
Vitamin D
21%
Obesity
17%
Autotransplantation
16%
Pancreatectomy
16%
Prevalence
16%
Body Mass Index
16%
Atherosclerosis
15%
Cardiovascular System
15%
Diabetes Mellitus
12%
Aldosterone
11%
Sex Hormone
11%
Hemoglobin A1c
11%
Chronic Pancreatitis
11%
Hyperglycemia
10%
Glycemic
10%
Hazard Ratio
9%
Supplementation
9%
Frailty
9%
Disease
9%
Impaired Glucose Tolerance
9%
Diabetes Prevention
9%
Renin
9%
Physical Activity
9%
Insulin Resistance
8%
Acetylsalicylic Acid
8%
Blood Glucose
8%
Odds Ratio
7%
Primary Prevention
7%
Sex Difference
7%
Meta-Analysis
7%
Coronary Artery Disease
7%
Cardiovascular Risk
7%
Glucose Metabolism
7%
Clinical Trial
7%
Insulin Dependent Diabetes Mellitus
6%
Glycon
6%
Acute Pancreatitis
6%
Metabolic Syndrome
6%
Randomized Clinical Trial
6%
Medical Care
6%
Type 2 Diabetes
6%
Drug Therapy
6%
Apoplexy
6%
Ischemic Heart Disease
6%
Oral Glucose Tolerance Test
6%
Patient with Type 2 Diabetes
5%
Homeostatic Model Assessment
5%
Keyphrases
Diabetes
64%
Type 2 Diabetes Mellitus (T2DM)
35%
Jackson Heart Study
31%
Vitamin D Supplementation
17%
African American
17%
Hemoglobin A1c (HbA1c)
17%
Older Adults
16%
Type 1 Diabetes Mellitus (T1DM)
16%
Aldosterone
15%
Cardiovascular Disease
13%
Obesity
12%
Vitamin D
12%
Fall Reduction
12%
Fasting Plasma Glucose
11%
Aging
11%
Cardiovascular Risk
11%
Adiposity
11%
Hazard Ratio
10%
Incident Diabetes
10%
Without Diabetes
10%
Coronary Artery Disease
9%
Body Mass Index
9%
Odds Ratio
9%
Total Pancreatectomy with Islet Autotransplantation
9%
Pre-diabetes (pre-DM)
9%
Hyperglycemia
8%
Patients with Diabetes
8%
Frailty
7%
Metformin
7%
American Diabetes Association
7%
Rare Variants
7%
Insulin Resistance
7%
Confidence Interval
7%
Lean Body Mass
7%
Fall Risk
7%
Diabetes Prevention Program
7%
Type I Diabetes
6%
Physical Function
6%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
6%
Aspirin
6%
Endocrine Society
6%
Program Outcomes
6%
Treatment Standards
6%
Cerebrovascular Reactivity
6%
Whole Genome Sequencing
6%
Meta-analysis
6%
25-hydroxyvitamin D (25OHD)
6%
Plasma Renin Activity
6%
Renin
6%
Metabolic Syndrome
6%